Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2020 | 10-2019 | 07-2019 | 04-2019 | 01-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 321 | 979 | 473 | 415 | 410 |
| Receivables | 156 | 220 | 373 | 134 | 129 |
| Inventories | 141 | 162 | 177 | 195 | 205 |
| TOTAL | $633 | $1,391 | $1,041 | $772 | $793 |
| Non-Current Assets | |||||
| PPE Net | 351 | 333 | 362 | 388 | 416 |
| Intangibles | 484 | 506 | 529 | 550 | 568 |
| TOTAL | $835 | $839 | $891 | $938 | $984 |
| Total Assets | $1,468 | $2,230 | $1,932 | $1,710 | $1,777 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 589 | 749 | 553 | 386 | 525 |
| Accrued Expenses | 103 | 128 | 185 | 137 | 125 |
| TOTAL | $692 | $877 | $738 | $523 | $650 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $4 | $7 | $10 |
| Total Liabilities | $692 | $877 | $742 | $530 | $660 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,891 | 79,994 | 79,994 | 75,096 | 74,113 |
| Common Shares | 800 | 800 | 768 | 741 | 717 |
| Retained earnings | -125,269 | -124,603 | -123,478 | -122,659 | -120,786 |
| TOTAL | $776 | $1,353 | $1,190 | $1,180 | $1,117 |
| Total Liabilities And Equity | $1,468 | $2,230 | $1,932 | $1,710 | $1,777 |